German Foreign Minister: Ukraine needs hard security.Xia Yiping, CEO of Extreme Vietnam: I am only a minority shareholder of the company, and Baidu has 80% of the voting rights. I learned from employees inside Extreme Vietnam that Xia Yiping, CEO of Extreme Vietnam, communicated with employee representatives about the company this afternoon. He revealed that the board of directors had a meeting the night before the 11th solution was released, and no agreement was reached on employee social security. It is not up to you to decide the plan that is released only after you get the resolution from the board of directors. "I said that I could take some money to solve the social security problem of employees, but in this case, neither shareholder stood up." He said that he is the CEO of the company, but he is only a minority shareholder and has decision-making power in business, but he has no decision-making power in the development of the company and needs the decision of the board of directors. 80% of the voting rights of the company are in Baidu. Baidu has just conducted a comprehensive audit of the company recently, and there are no problems. (Sina Technology)
US President-elect Trump: The Abraham Agreement will be expanded and Saudi Arabia will be added.Guotai Junan: The long-term incremental "option" brought by humanoid robots is expected to help the valuation of the rare earth sector rise. When looking forward to the strategy of the rare earth sector in 2025, Guotai Junan said that the market had expected that with the slowdown in the growth of core demand power such as new energy vehicles and wind power in the future, the demand for rare earth markets is under downward pressure. However, we expect that the rising consumption of magnetic materials for new energy vehicles and the warming demand for wind power are still expected to support the basic demand growth, and the demand for equipment renewal that began to land in 2024 is expected to become a new driving force for rare earth demand. On the supply side, an orderly pattern of domestic supply has been established, with many overseas planning increments but slow actual volume, and continuous supply-side constraints. In addition, the long-term incremental "options" brought by humanoid robots are also expected to help the valuation of the plate rise.Australia's ASX 200 index narrowed to 0.1%, and the Australian dollar increased. The just released Australian employment data was better than expected.
China Bank's RMB clearing volume in Australia exceeded 100 trillion yuan. According to Bank of China, recently, Bank of China Sydney Branch and Bank of China Hong Kong jointly held a RMB forum in Sydney to celebrate the 10th anniversary of being an Australian RMB clearing bank. As the only RMB clearing bank in the South Pacific at present, in the past ten years, China Bank has taken root in Australia and South Pacific, continuously expanded its clearing network, cooperated with four local banks and other financial institutions in Australia, and became the main channel for RMB clearing of local important banks, providing RMB clearing volume of more than 100 trillion yuan.HKEx: It is estimated that the T+1 settlement system will be ready by the end of 2025.CITIC Securities: The resonance between supply and demand of medical beauty accelerates the space expansion, and the difference in operating ability promotes the evolution of the industry structure. CITIC Securities Research Report stated that the medical beauty industry has both medical and consumption attributes, and the medical attribute has strong product-driven characteristics, while the consumption attribute has high operating ability requirements. The medical beauty botulinum toxin track is also affected by the dual attributes of medicine and consumption: 1) The increase in penetration rate, the acceleration of compliance substitution and the extension of indications have brought about high demand for medical beauty botulinum toxin, and with the recent supply expansion, the industry scale has experienced high growth; 2) The iteration of product innovation is slow, brand barriers are created through marketing, doctors are empowered through direct sales, and control is strengthened to enhance product competitiveness. Recently, a variety of medical botulinum toxins in China have been approved, and the promotion of low-priced products is expected to push up the penetration rate, and enterprises with strong operational capabilities will enter the market or promote the evolution of the pattern.